Mathers Edward T (CIK 1328625) reported 25 SEC Form 4 insider transactions across 5 companies over the past 18 months (most recent 2026-03-16). Recent activity: Buy RYTM (4,199 shares), Buy KRRO (207,100 shares), Buy RYTM (4,198 shares), Buy SGP (1.6M shares), Buy SGP (1.4M shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-16 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Director | Buy | 4,199 | $0 |
| 2026-03-12 | Korro Bio, Inc. (KRRO) | Insider | Buy | 207,100 | $2.3M |
| 2026-03-04 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Director | Buy | 4,198 | $0 |
| 2026-02-11 | SpyGlass Pharma, Inc. (SGP) | Insider | Buy | 1.6M | $0 |
| 2026-02-11 | SpyGlass Pharma, Inc. (SGP) | Insider | Buy | 1.4M | $0 |
| 2026-02-11 | SpyGlass Pharma, Inc. (SGP) | Insider | Buy | 1.4M | $0 |
| 2026-02-11 | SpyGlass Pharma, Inc. (SGP) | Insider | Buy | 737,962 | $0 |
| 2026-02-11 | SpyGlass Pharma, Inc. (SGP) | Insider | Buy | 937,500 | $15.0M |
| 2026-01-02 | OnKure Therapeutics, Inc. (OKUR) | Director | Buy | 3,911 | $0 |
| 2025-10-06 | NeueHealth, Inc. (NEUE) | Director | Sell | 276 | $1,863 |
| 2025-10-06 | NeueHealth, Inc. (NEUE) | Director | Sell | 280 | $1,890 |
| 2025-10-06 | NeueHealth, Inc. (NEUE) | Director | Buy | 186,128 | $1,861 |
| 2025-10-06 | NeueHealth, Inc. (NEUE) | Director | Buy | 189,195 | $1,892 |
| 2025-10-06 | NeueHealth, Inc. (NEUE) | Director | Sell | 674,554 | $0 |
| 2025-10-06 | NeueHealth, Inc. (NEUE) | Director | Buy | 1.7M | $16,568 |
| 2025-10-06 | NeueHealth, Inc. (NEUE) | Director | Sell | 2,455 | $16,571 |
| 2025-10-06 | NeueHealth, Inc. (NEUE) | Director | Buy | 607,536 | $6,075 |
| 2025-10-06 | NeueHealth, Inc. (NEUE) | Director | Sell | 900 | $6,075 |
| 2025-10-06 | NeueHealth, Inc. (NEUE) | Director | Buy | 124,085 | $1,241 |
| 2025-10-06 | NeueHealth, Inc. (NEUE) | Director | Sell | 182 | $1,228 |
| 2025-10-06 | NeueHealth, Inc. (NEUE) | Director | Sell | 2.4M | $0 |
| 2025-10-02 | OnKure Therapeutics, Inc. (OKUR) | Director | Buy | 4,125 | $0 |
| 2025-07-02 | OnKure Therapeutics, Inc. (OKUR) | Director | Buy | 4,694 | $0 |
| 2025-06-23 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Director | Buy | 4,000 | $0 |
| 2025-04-02 | OnKure Therapeutics, Inc. (OKUR) | Director | Buy | 2,580 | $0 |
Source: SEC Form 4 filings · as of 2026-03-16